<qa>  What is the maximum dose?A phase III study is conducted to determine the maximum-tolerated dose MTD, dose-limiting toxicity DLT, and efficacy of a combination chemotherapy using CPT-11 and Paclitaxel in pre-treated patients with metastatic gastric cancer. The usefulness of the this regimen is evaluated by response rate, median survival time, and progression free survival. 